NM_198904.4:c.354G>A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_198904.4(GABRG2):​c.354G>A​(p.Ala118Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0032 in 1,612,768 control chromosomes in the GnomAD database, including 131 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A118A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.016 ( 70 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 61 hom. )

Consequence

GABRG2
NM_198904.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.03

Publications

2 publications found
Variant links:
Genes affected
GABRG2 (HGNC:4087): (gamma-aminobutyric acid type A receptor subunit gamma2) This gene encodes a gamma-aminobutyric acid (GABA) receptor. GABA is the major inhibitory neurotransmitter in the mammlian brain, where it acts at GABA-A receptors, which are ligand-gated chloride channels. GABA-A receptors are pentameric, consisting of proteins from several subunit classes: alpha, beta, gamma, delta and rho. Mutations in this gene have been associated with epilepsy and febrile seizures. Multiple transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
GABRG2 Gene-Disease associations (from GenCC):
  • epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 74
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • febrile seizures, familial, 8
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • Dravet syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • generalized epilepsy with febrile seizures plus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • self-limited epilepsy with centrotemporal spikes
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 5-162097664-G-A is Benign according to our data. Variant chr5-162097664-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 129128.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.03 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0511 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_198904.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRG2
NM_198904.4
MANE Select
c.354G>Ap.Ala118Ala
synonymous
Exon 4 of 10NP_944494.1
GABRG2
NM_198903.2
c.354G>Ap.Ala118Ala
synonymous
Exon 4 of 11NP_944493.2
GABRG2
NM_001375343.1
c.354G>Ap.Ala118Ala
synonymous
Exon 4 of 10NP_001362272.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRG2
ENST00000639213.2
TSL:1 MANE Select
c.354G>Ap.Ala118Ala
synonymous
Exon 4 of 10ENSP00000491909.2
GABRG2
ENST00000414552.6
TSL:1
c.354G>Ap.Ala118Ala
synonymous
Exon 4 of 11ENSP00000410732.2
GABRG2
ENST00000639111.2
TSL:1
c.354G>Ap.Ala118Ala
synonymous
Exon 4 of 9ENSP00000492125.2

Frequencies

GnomAD3 genomes
AF:
0.0157
AC:
2377
AN:
151884
Hom.:
70
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0530
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00749
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000485
Gnomad OTH
AF:
0.0168
GnomAD2 exomes
AF:
0.00423
AC:
1055
AN:
249500
AF XY:
0.00330
show subpopulations
Gnomad AFR exome
AF:
0.0557
Gnomad AMR exome
AF:
0.00229
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000499
Gnomad OTH exome
AF:
0.00164
GnomAD4 exome
AF:
0.00190
AC:
2773
AN:
1460766
Hom.:
61
Cov.:
32
AF XY:
0.00165
AC XY:
1199
AN XY:
726740
show subpopulations
African (AFR)
AF:
0.0573
AC:
1913
AN:
33396
American (AMR)
AF:
0.00289
AC:
129
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26112
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39666
South Asian (SAS)
AF:
0.000255
AC:
22
AN:
86242
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53330
Middle Eastern (MID)
AF:
0.00417
AC:
24
AN:
5756
European-Non Finnish (NFE)
AF:
0.000394
AC:
438
AN:
1111234
Other (OTH)
AF:
0.00404
AC:
244
AN:
60334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
127
254
380
507
634
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0157
AC:
2382
AN:
152002
Hom.:
70
Cov.:
32
AF XY:
0.0156
AC XY:
1162
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.0530
AC:
2197
AN:
41476
American (AMR)
AF:
0.00748
AC:
114
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5168
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10540
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000485
AC:
33
AN:
67982
Other (OTH)
AF:
0.0166
AC:
35
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
109
218
328
437
546
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00530
Hom.:
4
Bravo
AF:
0.0184
EpiCase
AF:
0.000982
EpiControl
AF:
0.000652

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2 (1)
-
-
1
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2;C1969810:Febrile seizures, familial, 8 (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
6.2
DANN
Benign
0.64
PhyloP100
-1.0
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61735412; hg19: chr5-161524670; API